Recombinant Coxsackievirus B1 (Tucson Strain) VP1 (Tucson Strain) (VAng-Lsx0076)
Datasheet
Specifications
Source
Human
Target
Coxsackie Virus
Type
Viral Antigens
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
8 M Urea, 20 mM Phosphate, pH 8.0, 1 M Sodium Chloride, 0.1 % Polyoxyethylene (10) Tridecylether.
Purity
> 95 % pure by SDS-PAGE.
Storage
Store at -20 °C.
Antigen Information
Introduction
Coxsackie B is the name of a group of six serotypes of pathogenic enteroviruses that trigger illness ranging from mild gastrointestinal distress to full-fledged pericarditis and myocarditis, The various members of the Coxsackie B group were discovered almost entirely in the United States, appearing originally in Connecticut, Ohio, New York, and Kentucky, although a sixth member of the group has been found in the Philippines. That said, all six serotypes have a global distribution and are a relatively common cause of gastrointestinal upset.
Alternative Names
Coxsackie B1 virus VP1; Coxsackie B1 VP1; Coxsackievirus VP1; Coxsackievirus B1 VP1
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
